VASH1 and neoplasm: Therefore, immunotherapy has become a new breakthrough in the domain of tumor therapy after surgery, chemotherapy, radiotherapy, endocrine therapy, and targeted treatment.29,30 We found that VASH1 was mainly associated with iDC, macrophage, and NK cell infiltration.